Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biochem Mol Toxicol ; 36(5): e23024, 2022 May.
Article in English | MEDLINE | ID: mdl-35218269

ABSTRACT

Rotenone is used to generate Parkinson's disease (PD)-like symptoms in experimental animals. Octanoic acid (C8), is the principal fatty acid of medium-chain triglycerides in ketogenic diets. Beneficial effects of ketogenic diets were shown in PD. We applied proteomic methods to reveal the effects of octanoic acid in rotenone toxicity in zebrafish to gain information on the use of ketogenic diets in PD. Zebrafish were exposed to 5 µg/ml rotenone and octanoic acid (20 and 60 mg/ml) for 30 days. LC-MS/MS analysis was performed. Raw files were analyzed by Proteome Discoverer 2.4 software, peptide lists were searched against Danio rerio proteins. STRING database was used for protein annotations or interactions. 2317 unique proteins were quantified, 302 proteins were differentially expressed. Proteins involved in cell organization, biogenesis, transport, response to stimulus were most frequently expressed. Our study is first to report that the alterations in the expressions of proteins related to energy and redox system, stress response, and cytoskeleton proteins caused by rotenone exposure were normalized by octanoic acid treatment in zebrafish.


Subject(s)
Parkinson Disease , Rotenone , Animals , Caprylates , Chromatography, Liquid , Cytoskeletal Proteins/metabolism , Cytoskeleton/metabolism , Oxidation-Reduction , Parkinson Disease/metabolism , Proteomics , Rotenone/toxicity , Tandem Mass Spectrometry , Zebrafish/metabolism
2.
Int J Neurosci ; 130(6): 574-582, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31771386

ABSTRACT

Aim: The aim of this study is to investigate the possible protective effects of mitoquinone and oleandrin on rotenone induced Parkinson's disease in zebrafish. Materials and methods: Adult zebrafish were exposed to rotenone and mitoquinone for 30 days. Biochemical parameters were determined by spectrophotometric method and Parkinson's disease-related gene expressions were determined by reverse transcription polymerase chain reaction method. Measurement of neurotransmitters was performed by liquid chromatography tandem-mass spectrometry instrument. The accumulation of synuclein was demonstrated by immunohistochemical staining. In vitro thiazolyl blue tetrazolium bromide method was applied to determine the mitochondrial function of synaptosomal brain fractions using rotenone as a neurotoxic agent and mitoquinone and oleandrin as neuroprotective agents. Results: Mitoquinone improved the oxidant-antioxidant balance and neurotransmitter levels that were disrupted by rotenone. Mitoquinone also ameliorated the expressions of Parkinson's disease-related gene expressions that were disrupted by rotenone. According to thiazolyl blue tetrazolium bromide assay results, mitoquinone and oleandrin increased mitochondrial function which was decreased due to rotenone exposure. Conclusion: Based on the results of our study, positive effects of mitoquinone were observed in Parkinson's disease model induced by rotenone in zebrafish.


Subject(s)
Cardenolides/administration & dosage , Gene Expression/drug effects , Neuroprotective Agents/administration & dosage , Organophosphorus Compounds/administration & dosage , Parkinson Disease/metabolism , Ubiquinone/analogs & derivatives , Animals , Disease Models, Animal , Female , Fish Proteins/metabolism , Locomotion/drug effects , Male , Mitochondria/drug effects , Parkinsonian Disorders/chemically induced , Rotenone/administration & dosage , Synucleins/metabolism , Ubiquinone/administration & dosage , Zebrafish
3.
Int J Neurosci ; 129(4): 363-368, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30334640

ABSTRACT

AIM OF THE STUDY: Rotenone is a commonly used pesticide that inhibits complex I of the mitochondrial electron transport system. Rotenone exposed rats demonstrate many characteristics of Parkinson Disease (PD). Oxidative stress is one of the hallmarks of PD, being the major sources of ROS in the DA neurons. In recent years the strong connection between the intestinal environment and the function of the central nervous system (CNS) has gained widespread popularity. In order to explain the mechanism underlying the GI dysfunction in PD, we aimed to investigate oxidant-antioxidant status in the brain and intestine, as well as locomotor activity, in rotenone exposed zebrafish. MATERIALS AND METHODS: Adult zebrafish were exposed to 2 mg/L rotenone for 30 days. At the end of the experiment, locomotor activity was determined by simple observation. Lipid peroxidation (LPO), nitric oxide (NO) levels, superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST) activities were determined in the homogenates. RESULTS: Locomotor activity decreased in the rotenone exposed zebrafish. LPO increased in both brain and intestines whereas NO increased only in the brain. Decreased GST and CAT activities were found in both tissues whereas SOD activity decreased only in the intestines. CONCLUSION: As a conclusion, the results of our study support the connection between gut and brain axis in rotenone exposed zebrafish by means of oxidative stress and NO for the first time in literature.


Subject(s)
Brain/drug effects , Catalase/drug effects , Glutathione Transferase/drug effects , Insecticides/adverse effects , Intestines/drug effects , Lipid Peroxidation/drug effects , Locomotion/drug effects , Nitric Oxide/metabolism , Rotenone/adverse effects , Superoxide Dismutase/drug effects , Zebrafish Proteins/drug effects , Zebrafish/metabolism , Animals , Behavior, Animal/drug effects , Brain/enzymology , Female , Insecticides/administration & dosage , Intestines/enzymology , Male , Rotenone/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...